(Q44216337)

English

Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Stanislava Stosic-Grujicic

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Danijela Maksimović-Ivanić

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Miodrag L Lukic

object named as

M Lukic

5

0 references

author name string

D Miljkovic

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

V Trajkovic

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

M Mostarica Stojkovic

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

2955-2957

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mycophenolate mofetil and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903502-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil can prevent the development of diabetes in BB rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903502-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903502-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903502-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pentoxifylline prevents autoimmune mediated inflammation in low dose streptozotocin induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903502-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903502-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-1345(02)03502-9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44216337&oldid=2108628232"